BPC-157/TB-500 Blend (The “Wolverine Stack”) is a research formulation combining two synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 Fragment (TB-500). This synergistic pairing—informally referred to in research communities as the “Wolverine Stack”—is studied for its potential to accelerate cellular regeneration, angiogenesis, and tissue remodeling mechanisms under controlled laboratory conditions.

Preclinical investigations examine the complementary pathways of BPC-157 and TB-500, including modulation of nitric oxide signaling, actin polymerization, and collagen synthesis. Together, these peptides are explored for their combined potential in musculoskeletal injury models, vascular biology research, and wound-healing studies. All work is conducted exclusively within laboratory settings for scientific investigation.

Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of BPC-157/TB-500 outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).

Product Specifications:

• Purity: ≥99% (HPLC verified)
• Formulation: Lyophilized powder
• Composition: BPC-157 and TB-500 (synthetic peptides)
• Molecular Formula (approx.): C₁₀₇H₁₆₆N₂₈O₃₅
• Molecular Weight (approx.): 2315.4 g/mol
• Storage: Store at -20°C, protected from light and moisture

Source:
BPC-157 – PubChem |
TB-500 – PubChem